BNP Paribas Financial Markets’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2K Sell
1,508
-550
-27% -$8.73K ﹤0.01% 5219
2026
Q1
$33.2K Buy
2,058
+5
+0.2% +$87 ﹤0.01% 4903
2025
Q4
$37.9K Buy
2,053
+530
+35% +$9.69K ﹤0.01% 4806
2025
Q3
$27.4K Buy
1,523
+723
+90% +$13.3K ﹤0.01% 4824
2025
Q2
$15.5K Buy
800
+215
+37% +$4.05K ﹤0.01% 4710
2025
Q1
$9.08K Sell
585
-468
-44% -$8.37K ﹤0.01% 4739
2024
Q4
$18.7K Buy
+1,053
New +$18.2K ﹤0.01% 4738

Other funds holding MDWD

BNP Paribas Financial Markets's MDWD Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its MediWound (MDWD) stake by 27% in Q2 2026, selling an estimated $8.73K and leaving 1,508 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5219.

BNP Paribas Financial Markets first reported a position in MDWD in Q4 2024 and has held it in 7 quarters since. The position peaked at $37.9K in Q4 2025. 76 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • BNP Paribas Financial Markets held 1,508 shares of MediWound worth $22.2K as of Q2 2026.
  • BNP Paribas Financial Markets sold 550 MediWound shares in Q2 2026, an estimated $8.73K.
  • MediWound made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5219 holding.
  • BNP Paribas Financial Markets first reported a position in MediWound in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's MediWound position peaked at $37.9K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.